122 (PB-035) Poster - Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience.
Saved in:
| Title: | 122 (PB-035) Poster - Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience. |
|---|---|
| Authors: | Caldart, A.1 (AUTHOR), Fiorio, E.1 (AUTHOR), Zanelli, S.1 (AUTHOR), Biondani, P.1 (AUTHOR), Parolin, V.1 (AUTHOR), Pellini, F.2 (AUTHOR), Montemezzi, S.3 (AUTHOR), Nottegar, A.4 (AUTHOR), Caliò, A.4 (AUTHOR), Zampiva, I.1 (AUTHOR), Merler, S.1 (AUTHOR), Mongillo, M.1 (AUTHOR), Avesani, B.1 (AUTHOR), Borghesani, G.1 (AUTHOR), Giontella, E.1 (AUTHOR), Scarpa, A.5 (AUTHOR), Milella, M.1 (AUTHOR) |
| Source: | European Journal of Cancer. 2022 Supplement 1, Vol. 175, pS38-S39. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598049 |
|---|---|
| DOI: | 10.1016/S0959-8049(22)01453-8 |
